Table 2.
Treatments | IgG titer1 | Lesion score1 |
---|---|---|
Diet | ||
Control | 1,367.8 ± 161.52 | 0.139 ± 0.0463 |
XPC | 1,366.1 ± 159.79 | 0.097 ± 0.0459 |
Main effect P-value | 0.9939 | 0.5289 |
Challenge | ||
Nonchallenged | 72.7b ± 159.79 | 0.000b ± 0.0459 |
Rlow MG-challenged | 2,661.2a ± 161.52 | 0.236a ± 0.0463 |
Main effect P-value | 0.0001 | 0.0012 |
Diet-challenge | ||
Control and Nonchallenged | 79.0 ± 225.98 | 0.000 ± 0.0650 |
Control and Rlow MG-challenged | 2,656.6 ± 230.84 | 0.278 ± 0.0659 |
XPC and Nonchallenged | 66.3 ± 225.98 | 0.00 ± 0.0650 |
XPC and Rlow MG-challenged | 2,665.8 ± 225.98 | 0.194 ± 0.0650 |
Interaction P-value | 0.9616 | 0.5289 |
a,bMeans in a column within type of variable and main effect or interaction treatment with no common superscript differ significantly (P ≤ 0.05).
Bold indicates P < 0.05.
Abbreviations: Rlow MG, low passage R strain of Mycoplasma gallisepticum; XPC, original XPC.
Nine birds in each of 16 replicate units were used to calculate means in the diet and challenge treatment groups, and 9 birds in each of 8 replicate units were used to calculate means in the diet-challenge treatment combination groups.